Matches in Nanopublications for { ?s ?p "PI3K/Akt LY294002 kinase inhibitor preclinical Clark et al. 2002 (106) NF-?B PS-341 proteasome inhibitor Phase I and II Adams 2002 (111) Indeed, inhibition of NF-?B by proteasome inhibitor PS-341 is being evaluated in clinical studies for the treatment of refractory hematologic malignancies and as an adjuvant approach in combination with chemotherapy or radiation for a variety of cancers [42, 43]." ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- _3 value "PI3K/Akt LY294002 kinase inhibitor preclinical Clark et al. 2002 (106) NF-?B PS-341 proteasome inhibitor Phase I and II Adams 2002 (111) Indeed, inhibition of NF-?B by proteasome inhibitor PS-341 is being evaluated in clinical studies for the treatment of refractory hematologic malignancies and as an adjuvant approach in combination with chemotherapy or radiation for a variety of cancers [42, 43]." provenance.
- _3 value "PI3K/Akt LY294002 kinase inhibitor preclinical Clark et al. 2002 (106) NF-?B PS-341 proteasome inhibitor Phase I and II Adams 2002 (111) Indeed, inhibition of NF-?B by proteasome inhibitor PS-341 is being evaluated in clinical studies for the treatment of refractory hematologic malignancies and as an adjuvant approach in combination with chemotherapy or radiation for a variety of cancers [42, 43]." provenance.